G. Frisoni, J. Annoni, S. Becker, T. Brockmann, Markus Buerge, J. Démonet, D. Georgescu, A. Gietl, U. Hemmeter, S. Klöppel, T. Leyhe, A. Monsch, F. Rogantini, Delphine Roulet Schwab, E. Savaskan, K. Schaller, A. von Gunten, G. Gold
{"title":"瑞士利益相关者对阿尔茨海默病抗痴呆药物的立场声明","authors":"G. Frisoni, J. Annoni, S. Becker, T. Brockmann, Markus Buerge, J. Démonet, D. Georgescu, A. Gietl, U. Hemmeter, S. Klöppel, T. Leyhe, A. Monsch, F. Rogantini, Delphine Roulet Schwab, E. Savaskan, K. Schaller, A. von Gunten, G. Gold","doi":"10.3390/ctn5020014","DOIUrl":null,"url":null,"abstract":"The present document represents the position of Swiss health-care associations, clinical and research centers, research-supporting foundations, and the association Alzheimer Switzerland regarding the care of persons with dementia and Alzheimer’s disease. We claim that dementia is not part of normal aging but a disease developing more frequently in old age; early diagnosis and treatment of dementia is paramount; all patients with dementia have the right to receive state-of-the-art treatments; more intense information, education, and counseling on dementia are necessary; media should provide balanced and fair reporting of scientific discoveries on Alzheimer’s and dementia; all patients with dementia have the right to be treated; anti-dementia drugs should be used and accompanied by listening, compassion, and understanding.","PeriodicalId":242430,"journal":{"name":"Clinical and Translational Neuroscience","volume":"192 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Position Statement on Anti-Dementia Medication for Alzheimer’s Disease by Swiss Stakeholders\",\"authors\":\"G. Frisoni, J. Annoni, S. Becker, T. Brockmann, Markus Buerge, J. Démonet, D. Georgescu, A. Gietl, U. Hemmeter, S. Klöppel, T. Leyhe, A. Monsch, F. Rogantini, Delphine Roulet Schwab, E. Savaskan, K. Schaller, A. von Gunten, G. Gold\",\"doi\":\"10.3390/ctn5020014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The present document represents the position of Swiss health-care associations, clinical and research centers, research-supporting foundations, and the association Alzheimer Switzerland regarding the care of persons with dementia and Alzheimer’s disease. We claim that dementia is not part of normal aging but a disease developing more frequently in old age; early diagnosis and treatment of dementia is paramount; all patients with dementia have the right to receive state-of-the-art treatments; more intense information, education, and counseling on dementia are necessary; media should provide balanced and fair reporting of scientific discoveries on Alzheimer’s and dementia; all patients with dementia have the right to be treated; anti-dementia drugs should be used and accompanied by listening, compassion, and understanding.\",\"PeriodicalId\":242430,\"journal\":{\"name\":\"Clinical and Translational Neuroscience\",\"volume\":\"192 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-08-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Translational Neuroscience\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3390/ctn5020014\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Translational Neuroscience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/ctn5020014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Position Statement on Anti-Dementia Medication for Alzheimer’s Disease by Swiss Stakeholders
The present document represents the position of Swiss health-care associations, clinical and research centers, research-supporting foundations, and the association Alzheimer Switzerland regarding the care of persons with dementia and Alzheimer’s disease. We claim that dementia is not part of normal aging but a disease developing more frequently in old age; early diagnosis and treatment of dementia is paramount; all patients with dementia have the right to receive state-of-the-art treatments; more intense information, education, and counseling on dementia are necessary; media should provide balanced and fair reporting of scientific discoveries on Alzheimer’s and dementia; all patients with dementia have the right to be treated; anti-dementia drugs should be used and accompanied by listening, compassion, and understanding.